TELA Bio, Inc. (NASDAQ: TELA) reported Q2 EPS of ($0.46), $0.06 better than the analyst estimate of ($0.52). Revenue for the quarter came in at $14.5 million versus the consensus estimate of $14.39 million.

For earnings history and earnings-related data on TELA Bio, Inc. (TELA) click here.